Generic Name |
Olaratumab | |
---|---|---|
IND |
IMC-3G3 | |
Brand Name (US) |
||
Manufacturer |
ImClone | |
Drug Type |
monoclonal antibody | |
Delivery |
Intravenous | |
Approval Status |
Phase 2 | |
Indications |
||
Overall Strategy |
KIT Protein Based | |
Strategy |
Block PDGFRA | |
Drug Category |
PDGFRa inhibitor |
IMC-3G3, a fully human monoclonal antibody of the immunoglobulin G subclass 1, specifically binds to the human PDGF receptor alpha (PDGFRalpha) with high affinity and blocks PDGF ligand binding and PDGFRalpha activation
ImClone was acquired by Eli Lilly in 2008.